Empiric antifungal therapy in patients with febrile neutropenia.
about
Risk factors for early invasive fungal disease in critically ill patients.Use of antifungal drugs in hematologyVoriconazole in clinical practice.Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients.Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
P2860
Empiric antifungal therapy in patients with febrile neutropenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Empiric antifungal therapy in patients with febrile neutropenia.
@en
Empiric antifungal therapy in patients with febrile neutropenia.
@nl
type
label
Empiric antifungal therapy in patients with febrile neutropenia.
@en
Empiric antifungal therapy in patients with febrile neutropenia.
@nl
prefLabel
Empiric antifungal therapy in patients with febrile neutropenia.
@en
Empiric antifungal therapy in patients with febrile neutropenia.
@nl
P2093
P2860
P356
P1433
P1476
Empiric antifungal therapy in patients with febrile neutropenia.
@en
P2093
Conan MacDougall
Jason C Gallagher
Jenna J Ferrara
P2860
P304
P356
10.1592/PHCO.31.4.369
P407
P577
2011-04-01T00:00:00Z